ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.64
0.22%
US Tech 100
20,266.40
0.33%
S&P 500
5,969.34
0.35%
US Dollar vs CAD
1.39805
-0.03%
Bitcoin
98,898.72
-0.14%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF) Share Price

Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF)

USOTC
0.000001
0.00
(0.00%)
Closed November 23 3:00PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.000001
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000001 52 Week Range 0.0001
Market Cap
120.378
Previous Close
0.000001
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
250
Shares Outstanding
120,377,529
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0.05
Revenue
35.43M
Net Profit
-5.74M

About Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed... Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed via its dedicated sales force and digital technology mySYNCH in the USA and Australia-New Zealand, and via distributors in other markets. Parnell has a rapidly growing contract manufacturing business supplying industry majors with specialized sterile injectable products. In companion animal, Parnell manufactures and markets its proprietary canine osteoarthritis brands Zydax and Glyde. For more information on the company and its products, please visit www.parnell.com. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.parnell.com
Headquarters
Sydney, New South Wales, Aus
Founded
-
Parnell Pharmaceuticals Holdings Ltd (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PARNF. The last closing price for Parnell Pharmaceuticals (CE) was US$0. Over the last year, Parnell Pharmaceuticals (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.0001.

Parnell Pharmaceuticals (CE) currently has 120,377,529 shares outstanding. The market capitalization of Parnell Pharmaceuticals (CE) is US$120.38 . Parnell Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of 0.00.

Ask ADVFN Intelligence (AI)

PARNF Latest News

More News

Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

December 19 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...

OVERLAND PARK, Kan., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

December 09 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility

OVERLAND PARK, Kan., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

November 22 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016

OVERLAND PARK, Kansas, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

November 02 2016
GlobeNewswire Inc.

Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016

OVERLAND PARK, Kan., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

October 27 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016

OVERLAND PARK, Kan., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

August 04 2016
GlobeNewswire Inc.

Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016

OVERLAND PARK, Kan., July 26, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

July 26 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial

OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

May 31 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock

OVERLAND PARK, Kan., May 12, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

May 12 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update

Parnell continues to grow rapidly with revenue increasing 43% for the three months ended March 31, 2016OVERLAND PARK, Kan., April 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings...

April 22 2016
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
12001.0E-61.0E-61.0E-62501.0E-6CS
26-9.9E-5-990.00010.00011.0E-611754.734E-5CS
52-9.9E-5-990.00010.00011.0E-634467.812E-5CS
156-9.9E-5-990.00010.14821.0E-6101930.00215528CS
260-0.147099-99.99932019030.14710.891.0E-6125910.21060008CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NEPTFNeptune Wellness Solutions Inc (CE)
US$ 0.0238
(2,379,900.00%)
13.46k
CNVIFConavi Medical Corporation (PK)
US$ 0.58
(82,757.14%)
2.25k
FUNFFFansUnite Entertainment Inc (CE)
US$ 0.00055
(54,900.00%)
342.7k
RQHTFReliq Health Technologies Inc (CE)
US$ 0.0003
(29,900.00%)
219.11k
ELOXEloxx Pharmaceuticals Inc (CE)
US$ 0.0001
(9,900.00%)
1.53k
FDVXFFenixOro Gold Corporation (CE)
US$ 0.000001
(-100.00%)
10k
TMPOQTempo Automation Holdings Inc (CE)
US$ 0.000001
(-99.98%)
200
HLLPFHello Pal International Inc (CE)
US$ 0.000001
(-99.90%)
6k
MOTSMotus GI Holdings Inc (CE)
US$ 0.000001
(-99.88%)
649
BTAEFBeta Energy Corporation (CE)
US$ 0.000001
(-99.67%)
655
RSHNRushNet Inc (PK)
US$ 0.00015
(-25.00%)
502.31M
EARIEntertainment Arts Research Inc (PK)
US$ 0.0001
(0.00%)
428.38M
ASTAAstra Veda Corporation (PK)
US$ 0.0002
(-33.33%)
364.38M
RDARRaadr Inc (PK)
US$ 0.0009
(50.00%)
276.07M
CGACCode Green Apparel Corp (PK)
US$ 0.00065
(44.44%)
225.16M

Discussion

View Full Feed
trunkmonk trunkmonk 27 seconds ago
this is going up 7 times 70
XRPUSD
facts_matter14 facts_matter14 32 seconds ago
BEST SELLERS RANK (BSR) shows POSVOS sales are happening at a rate of under 250 per year. (Even though the Q3 showed less than 30 were sold in the quarter)

And I’m going to post about it 24/7/365.

Every holiday, every day that ends in “Y”, multiple times per day, all th
SRMX
MiamiGent MiamiGent 1 minute ago
Oh yeah, they're quiet now because they are plotting.
WhAtEvA1 WhAtEvA1 2 minutes ago
Again, like I said before, you always manufacture "false narratives " in your head and run with it.
RDGL
cottonmather cottonmather 3 minutes ago
Bill Holter. Gold, BTC, USD. 27 minutes. https://youtu.be/Iiu83S_Hu5s?si=KpbVzCCjLAearXuv
trunkmonk trunkmonk 3 minutes ago
nice observation, its exactly what I saw in 1999. my friend Tony from Solvay NY would ask me what do you think of this, what do you think of that. each time i said looks good buy it, it will go up......he said how do you do that, i said they all did, the ones picked were decent to begin with. Back t
XRPUSD
Peter J Peter J 4 minutes ago
He, SSC, don't you want to see the share price go up?

Those 10.000 posts must pay out at some point I assume?


ERHE
CrossFireTrader CrossFireTrader 4 minutes ago
Of course no mention of the acquisition it's Quiet 🤫 Time. 
GDVM
nowwhat2 nowwhat2 4 minutes ago
Yeah / No / Well......Whatever, but that just ain't going to happen when ;

Pictures tell 1000 words.....


https://investorshub.advfn.com/uimage/uploads/2024/11/23/bwrkmTA_TRUNK_VERBAL.jpg


https://investorshub.advfn.com/uimage/uploads/2024
BTCUSD
longrider51 longrider51 5 minutes ago
The web conference will be no later than 12/6.
There has been a delay in the presentation. If that was from Ben/IR, you clearly did not state that, nor would it matter, given KBLB prior assertions. UPOD, not OPUD!
KBLB
glenn1919 glenn1919 5 minutes ago
PLBY.......GLBS......CAN.........CLIK.......https://stockcharts.com/h-sc/ui?s=CLIK&p=D&yr=0&mn=3&dy=0&id=p11960084343
CLIK GLBS PLBY
sentiment_stocks sentiment_stocks 6 minutes ago
and the experiments were carried out and completed by the Flaskworks team

Yes but the experiments are already done… and importantly, done using the Flaskworks’ Edens.

So next up…. Evaluating the data.
NWBO
JFR161162 JFR161162 6 minutes ago
Dstock,

Look at the charts of PFE, MRK and ANZ over the last 6 months. The boards of these companies are in a panic mode. They need to take major moves to stimulate their stock price. With huge capital available, they need to choose between buyback programs and/or massive acquisitions.My
MRK NWBO PFE
CrossFireTrader CrossFireTrader 6 minutes ago
Relax Old Man...Melvin is getting ready to butter ur toast, and pour a little bit of Honey on it as well. Take a break, check back 2nd Quarter of 2025, and no loading !!! I'm trying to beat you to 10M
GDVM
quester614 quester614 6 minutes ago
Some PPL just can't connect the dots. LOLOLOLOL
https://investorshub.advfn.com/uimage/uploads/2024/11/23/rhqjxScreenshot_2024-11-23_9.45.18_AM.png
XERI
kindo kindo 7 minutes ago
Golf can I ask you a question?
What made you invest here a few years ago in the first place?
What did you you see that caught your eye?
AFFU
glenn1919 glenn1919 8 minutes ago
QMCO.......COMM.......TALK........WLDS......GFAI.....................https://stockcharts.com/h-sc/ui?s=WLDS&p=D&yr=0&mn=3&dy=0&id=p11960084343
GFAI QMCO WLDS
JPetroInc JPetroInc 8 minutes ago
Oh its coming Sunny

it will be brought up to us like white glove room service - on a silver platter

we stand on the shoulders of giants here

and despite the setbacks, air pockets & altitude drops, endless waiting, and constant past tense barage of relent
MONI
nagoya1 nagoya1 9 minutes ago
The guy keeps on posting libor dockets every time the courts deposit a new one, I don't remember what amount he's imagining the GSEs receive...
At least the Libor case gets judicial news, our incompetent bozo has been hibernating for the longest time.
Lambreath is a perfect example of
FMCC
Cowboy1966 Cowboy1966 10 minutes ago
Just what he needs are new projects, he has yet to complete all the other projects he says he has going on. Just another bag of lies.
APRU
DiscoverGold DiscoverGold 10 minutes ago
New Street-High Price Target for NVDA
By: TrendSpider | November 23, 2024

• NEW STREET-HIGH PRICE TARGET FOR NVIDIA

After this week’s earnings, Rosenblatt raised its $NVDA price target from $200 to $220—a staggering +55% upside from current levels.
NVDA
glenn1919 glenn1919 11 minutes ago
DEVS....BBAI......DOUG......SRFM.......NINE........................https://stockcharts.com/h-sc/ui?s=DOUG&p=D&yr=0&mn=3&dy=0&id=p11960084343
BBAI DEVS SRFM
tryn2 tryn2 11 minutes ago
Thanks Doc for your estimates...🙂
NWBO

Your Recent History

USOTC
PARNF
Parnell Pharmaceuticals (CE)
BOV
DASA3Q
DASA ON
LSE
0A76
British American Tobacco
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved